Lifevantage (LFVN) FCF Margin (2010 - 2026)
Lifevantage's (LFVN) quarterly FCF Margin came in at 59.21% in Q2 2026, up 5769.0% on a YoY basis from 1.01% in Q2 2025, and up 550.81% quarter-over-quarter from 9.1% in Q1 2026.
Powered by 
Analysis
Lifevantage (LFVN) FCF Margin (2010 - 2026) Analysis & Trends
Lifevantage (LFVN) has reported FCF Margin for 17 consecutive years, with 59.21% the latest figure, recorded in Q2 2026.
- For the quarter ending Q2 2026, FCF Margin rose 5769.0% year-over-year to 59.21%; the trailing twelve-month figure through Jun 2026 stood at 4.55% (down 4.0% YoY), and the FY2026 full-year result was 3.65%, down 94.0% from the prior year.
- FCF Margin rose to 59.21% in Q2 2026 per LFVN's latest filing, from 9.1% in the prior quarter.
- Across five years, FCF Margin topped out at 59.21% in Q2 2026 and bottomed at 5.77% in Q3 2025.
- Historically, FCF Margin has averaged 6.33% across 5 years, with a median of 4.03% in 2023.
- The sharpest annual moves came in 2022 and 2026: FCF Margin slumped 948 bps in 2022, then jumped 5769 bps in 2026.
- Over 5 years, FCF Margin stood at 0.24% in 2022, then soared by 871 bps to 2.35% in 2023, then surged by 446 bps to 12.85% in 2024, then plunged by 73 bps to 3.49% in 2025, then surged by 1597 bps to 59.21% in 2026.
- According to Business Quant data, FCF Margin over the past three periods registered 59.21%, 9.1%, and 3.49% for Q2 2026, Q1 2026, and Q4 2025 respectively.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Colgate Palmolive | 70.49 Bn | 69.12 Bn | 3.30 Bn | 16.17% |
| 2 | Kenvue | 34.17 Bn | 33.06 Bn | 2.30 Bn | 15.78% |
| 3 | Kimberly Clark | 32.78 Bn | 31.82 Bn | 1.60 Bn | 13.27% |
| 4 | Bath & Body Works | 3.74 Bn | 2.95 Bn | 692.00 Mn | - |
| 5 | Prestige Consumer Healthcare | 2.29 Bn | 2.23 Bn | - | - |
| 6 | Perrigo | 1.92 Bn | 1.52 Bn | 313.90 Mn | 6.68% |
| 7 | Herbalife | 1.28 Bn | 912.76 Mn | 1.03 Bn | 1.63% |
| 8 | Edgewell Personal Care | 1.22 Bn | 824.55 Mn | 242.50 Mn | 18.08% |
| 9 | TFA Therapeutics | 1.02 Bn | 1.02 Bn | - | - |
| 10 | Lifevantage | 79.78 Mn | 64.86 Mn | 33.04 Mn | 59.21% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 59.21% |
| Mar 31, 2026 | 9.10% |
| Dec 31, 2025 | 3.49% |
| Sep 30, 2025 | -5.77% |
| Jun 30, 2025 | 1.52% |
| Mar 31, 2025 | 3.25% |
| Dec 31, 2024 | 12.85% |
| Sep 30, 2024 | -1.97% |
| Jun 30, 2024 | 4.71% |
| Mar 31, 2024 | 5.81% |
| Dec 31, 2023 | 2.35% |
| Sep 30, 2023 | 7.07% |
| Jun 30, 2023 | 5.99% |
| Mar 31, 2023 | 4.56% |
| Dec 31, 2022 | 0.24% |
| Sep 30, 2022 | -4.00% |
| Jun 30, 2022 | 4.93% |
| Mar 31, 2022 | 0.61% |
| Dec 31, 2021 | 6.75% |
| Sep 30, 2021 | 0.16% |